STAAR Surgical Company to Present at Upcoming Investor Conferences

MONROVIA, Calif., May 21, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in three upcoming investor conferences to review the Company’s recent financial results and business developments with investors and interested parties.

STAAR Surgical will present at the 38^th Annual Deutsche Bank 2013 Healthcare Conference in Boston at the Westin Waterfront Hotel on Wednesday, May 29, 2013 at 10:40 a.m. ET. Barry G. Caldwell, President and CEO and Hans Blickensdoerfer, President, Europe, Middle East, Africa, will be presenting at the conference.

The Benchmark Company One-on-One Investor Conference will be held on Thursday, May 30, 2013 at the Pfister Hotel in Milwaukee, Wisconsin. Barry Caldwell and Hans Blickensdoerfer will meet with interested investors in a series of one-on-one meetings.

The Company will also present at the Jefferies 2013 Global Healthcare Conference at the Grand Hyatt Hotel in New York on Thursday, June 6, 2013 at 2:00 p.m. ET. Barry Caldwell and Sam Gesten, General Counsel, will be presenting at the conference.

STAAR will offer a live video webcast of its presentations at Deutsche Bank and Jefferies on the Company’s website, www.staar.com, under Investor Information. An archived replay of these presentations will be available for 90 days following the event date, also at www.staar.com. The Benchmark conference does not provide for companies to webcast the event.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or “ICL.” A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.” Over 350,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company’s website at www.staar.com.

SOURCE STAAR Surgical Company

Help employers find you! Check out all the jobs and post your resume.